GPA

Clinical trials for GPA explained in plain language.

Never miss a new study

Get alerted when new GPA trials appear

Sign up with your email to follow new studies for GPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug hope for GPA patients with stubborn ENT symptoms

Disease control Not yet recruiting

This study tests whether adding TAVNEOS to standard treatment helps control ear, nose, and throat symptoms in people with granulomatosis with polyangiitis (GPA). About 30 adults with active ENT disease will receive either TAVNEOS or a placebo for 52 weeks. The goal is to see if m…

Matched conditions: GPA

Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

GPA

Get alerted when new GPA trials appear

New drug hope for GPA patients with stubborn ENT symptoms